PharVision Advisers’s Tempus AI TEM Stock Holding History

PharVision Advisers’s Portfolio TEM Stock Details TEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,389	Closed	-$200K	–	675
2025 Q4	$200K	Buy	+3,389	New	+$265K	0.1%	560

Other funds holding TEM

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

GWMR

GC Wealth Management RIA Cambridge, Massachusetts $1.73B AUM 16.14% 1-Year Est. Return

SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

PharVision Advisers's TEM Position: Q1 2026 in Review

PharVision Advisers sold out of Tempus AI (TEM) in Q1 2026, closing a stake of 3,389 shares — an estimated $200K sold.

PharVision Advisers first reported a position in TEM in Q4 2025 and held it in 1 quarter. The position peaked at $200K in Q4 2025. 425 funds tracked by Wall St. Rank hold TEM as of Q1 2026.

PharVision Advisers reported no remaining Tempus AI position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 3,389 Tempus AI shares in Q1 2026, an estimated $200K.
PharVision Advisers first reported a position in Tempus AI in Q4 2025 and held it in 1 quarter.
PharVision Advisers's Tempus AI position peaked at $200K in Q4 2025.
425 funds tracked by Wall St. Rank held Tempus AI as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.